KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Net Income - Minority (2020 - 2025)

Thermo Fisher Scientific's Net Income - Minority history spans 6 years, with the latest figure at -$7.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Net Income - Minority fell 121.21% year-over-year to -$7.0 million, compared with a TTM value of -$7.0 million through Dec 2025, down 121.21%, and an annual FY2025 reading of -$7.0 million, down 121.21% over the prior year.
  • Net Income - Minority for Q4 2025 was -$7.0 million at Thermo Fisher Scientific, roughly flat from -$7.0 million in the prior quarter.
  • The five-year high for Net Income - Minority was $35.0 million in Q2 2025, with the low at -$62.0 million in Q4 2021.
  • Average Net Income - Minority over 5 years is -$16.3 million, with a median of -$7.0 million recorded in 2025.
  • Year-over-year, Net Income - Minority plummeted 520.0% in 2021 and then surged 211.11% in 2024.
  • Tracing TMO's Net Income - Minority over 5 years: stood at -$62.0 million in 2021, then rose by 12.9% to -$54.0 million in 2022, then surged by 120.37% to $11.0 million in 2023, then skyrocketed by 200.0% to $33.0 million in 2024, then plummeted by 121.21% to -$7.0 million in 2025.
  • Per Business Quant, the three most recent readings for TMO's Net Income - Minority are -$7.0 million (Q4 2025), -$7.0 million (Q3 2025), and $35.0 million (Q2 2025).